SINGH GURDEV DAVE enters VIVOS THERAPEUTICS, INC. with 3.92M shares across direct and indirect positions
This filing by SINGH GURDEV DAVE (Chief Medical Officer) establishes the baseline for all future Form 4 insider transaction reports at VIVOS THERAPEUTICS, INC..
Direct Indirect
Filed: 12/10/2020ACC: 0001493152-20-023332
DirectorOfficer10% Owner· Chief Medical Officer
Since Dec 2020
3.92M
Baseline shares
18% direct
700K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
2
Security positions
3.22M indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned3.22M
Series A Preferred Stock
DirectShares owned700K
Total
700K direct·3.22M indirect3.92M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.22M | Indirect |
| Series A Preferred Stock | 700K | Direct |
| Total | 3.92M | 700K direct·3.22M indirect |
Derivative Holdings0
No derivative holdings reported